SmaI drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (6)
Papers in which this entity is mentioned.
- Long-term spatial tracking of cells affected by environmental insults. (2020)
- Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. (2013)
- Temporally- and spatially-regulated transcriptional activity of the nicotinic acetylcholine receptor beta4 subunit gene promoter. (2010)
- Platelet-derived growth factor receptor beta is critical for zebrafish intersegmental vessel formation. (2010)
- The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles. (2009)
- EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. (1998)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| smai | drug | 6 | 6 |